Clinical Research Directory
Browse clinical research sites, groups, and studies.
ADAM17 and Vascular Function in Diabetes
Sponsor: University of Missouri-Columbia
Summary
The objective of this project is to determine the extent to which administration of the dietary supplement phosphatidylserine (PS), a competitive inhibitor of ADAM17 sheddase activity, effects vascular function and insulin-stimulated leg blood flow in subjects with T2D.
Official title: Targeting ADAM17 Activity for Correction of Vascular Insulin Resistance in Type 2 Diabetes
Key Details
Gender
All
Age Range
45 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2023-03-01
Completion Date
2025-11-01
Last Updated
2025-07-17
Healthy Volunteers
No
Conditions
Interventions
Placebo
4 weeks of placebo supplements
Phosphatidylserine
4 weeks of phosphatidylserine supplements
Locations (1)
University of Missouri- NextGen Clinical Translational Science Unit
Columbia, Missouri, United States